North Dakota Gov. Doug Burgum has handed his final budget blueprint to lawmakers that includes a rosy picture based largely ...

The natural gas market is drifting lower during the session on Wednesday, as the markets are looking to digest the massive gains on the way up. At this point, the market looks like it is trying to ...

The Bitcoin market continues to see a lot of consolidation at the moment, as the markets continue to try and look for a ...

Outlook Therapeutics (OTLK) announced that the National Institute for Health and Care Excellence, NICE, has recommended LYTENAVA, as an option ...

First positive reimbursement decision worldwide for LYTENAVA™; First launch anticipated in H1 2025 LYTENAVA™ is the first and only approved ophthalmic formulation of bevacizumab for the treatment of ...

An announcement from Outlook Therapeutics ( (OTLK) ) is now available.

Discover the best CRM for Outlook integration to enhance your productivity. Compare different solutions and explore your ...

Shares of AT&T Inc. T rose sharply during Tuesday's session after the company updated its 2024 guidance, raising the bottom ...

Fintel reports that on December 2, 2024, Chardan Capital downgraded their outlook for Outlook Therapeutics (NasdaqCM:OTLK) from Buy to Neutral. Analyst Price Forecast Suggests 1,865.37% Upside As of ...

In the assessment of 12-month price targets, analysts unveil insights for Voyager Therapeutics, presenting an average target ...

Outlook Therapeutics (NASDAQ:OTLK – Free Report) had its target price reduced by BTIG Research from $50.00 to $9.00 in a ...